Elanco Animal Health Inc
NYSE:ELAN
Income Statement
Earnings Waterfall
Elanco Animal Health Inc
Revenue
|
4.4B
USD
|
Cost of Revenue
|
-1.9B
USD
|
Gross Profit
|
2.5B
USD
|
Operating Expenses
|
-2.2B
USD
|
Operating Income
|
326m
USD
|
Other Expenses
|
-1.6B
USD
|
Net Income
|
-1.2B
USD
|
Income Statement
Elanco Animal Health Inc
Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||
Revenue |
2 958
N/A
|
3 022
+2%
|
3 067
+1%
|
3 062
0%
|
3 073
+0%
|
3 083
+0%
|
3 071
0%
|
2 998
-2%
|
2 802
-7%
|
2 921
+4%
|
3 271
+12%
|
3 855
+18%
|
4 548
+18%
|
4 789
+5%
|
4 764
-1%
|
4 747
0%
|
4 643
-2%
|
4 538
-2%
|
4 411
-3%
|
4 439
+1%
|
4 321
-3%
|
4 363
+1%
|
4 417
+1%
|
|
Gross Profit | ||||||||||||||||||||||||
Cost of Revenue |
(1 573)
|
(1 566)
|
(1 574)
|
(1 558)
|
(1 482)
|
(1 473)
|
(1 470)
|
(1 459)
|
(1 399)
|
(1 481)
|
(1 667)
|
(1 903)
|
(2 158)
|
(2 219)
|
(2 132)
|
(2 072)
|
(2 005)
|
(1 975)
|
(1 913)
|
(1 898)
|
(1 848)
|
(1 863)
|
(1 931)
|
|
Gross Profit |
1 385
N/A
|
1 456
+5%
|
1 493
+3%
|
1 504
+1%
|
1 591
+6%
|
1 611
+1%
|
1 601
-1%
|
1 538
-4%
|
1 403
-9%
|
1 440
+3%
|
1 604
+11%
|
1 952
+22%
|
2 390
+22%
|
2 571
+8%
|
2 632
+2%
|
2 675
+2%
|
2 638
-1%
|
2 563
-3%
|
2 498
-3%
|
2 541
+2%
|
2 473
-3%
|
2 500
+1%
|
2 486
-1%
|
|
Operating Income | ||||||||||||||||||||||||
Operating Expenses |
(1 223)
|
(1 202)
|
(1 179)
|
(1 179)
|
(1 196)
|
(1 222)
|
(1 231)
|
(1 237)
|
(1 189)
|
(1 338)
|
(1 686)
|
(1 970)
|
(2 306)
|
(2 422)
|
(2 328)
|
(2 282)
|
(2 232)
|
(2 159)
|
(2 114)
|
(2 118)
|
(2 130)
|
(2 165)
|
(2 160)
|
|
Selling, General & Administrative |
(763)
|
(747)
|
(735)
|
(736)
|
(746)
|
(759)
|
(760)
|
(761)
|
(723)
|
(808)
|
(997)
|
(1 163)
|
(1 385)
|
(1 450)
|
(1 403)
|
(1 375)
|
(1 333)
|
(1 289)
|
(1 265)
|
(1 272)
|
(1 282)
|
(1 297)
|
(1 285)
|
|
Research & Development |
(250)
|
(247)
|
(247)
|
(246)
|
(253)
|
(264)
|
(270)
|
(273)
|
(263)
|
(282)
|
(329)
|
(351)
|
(386)
|
(392)
|
(369)
|
(361)
|
(349)
|
(333)
|
(321)
|
(321)
|
(320)
|
(328)
|
(327)
|
|
Depreciation & Amortization |
(210)
|
(208)
|
(197)
|
(197)
|
(197)
|
(199)
|
(200)
|
(203)
|
(203)
|
(248)
|
(360)
|
(455)
|
(535)
|
(581)
|
(556)
|
(546)
|
(550)
|
(537)
|
(528)
|
(525)
|
(528)
|
(540)
|
(548)
|
|
Operating Income |
162
N/A
|
254
+57%
|
314
+24%
|
325
+4%
|
395
+21%
|
388
-2%
|
370
-5%
|
302
-19%
|
214
-29%
|
103
-52%
|
(82)
N/A
|
(18)
+79%
|
83
N/A
|
149
+79%
|
304
+104%
|
393
+29%
|
406
+3%
|
404
0%
|
384
-5%
|
423
+10%
|
343
-19%
|
335
-2%
|
326
-3%
|
|
Pre-Tax Income | ||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
(30)
|
(42)
|
(63)
|
(81)
|
(79)
|
(75)
|
(79)
|
(108)
|
(150)
|
(195)
|
(230)
|
(242)
|
(236)
|
(227)
|
(234)
|
(234)
|
(241)
|
(253)
|
(260)
|
(272)
|
(277)
|
|
Non-Reccuring Items |
(284)
|
(272)
|
(130)
|
(152)
|
(116)
|
(181)
|
(186)
|
(239)
|
(327)
|
(512)
|
(627)
|
(656)
|
(836)
|
(685)
|
(634)
|
(572)
|
(359)
|
(274)
|
(183)
|
(177)
|
(126)
|
(1 158)
|
(1 169)
|
|
Gain/Loss on Disposition of Assets |
4
|
4
|
1
|
0
|
0
|
0
|
0
|
4
|
49
|
49
|
4
|
46
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(9)
|
(24)
|
(41)
|
(51)
|
(46)
|
(47)
|
(27)
|
(26)
|
(20)
|
110
|
178
|
134
|
134
|
8
|
(5)
|
(14)
|
(11)
|
(8)
|
(32)
|
(26)
|
(55)
|
(56)
|
(75)
|
|
Pre-Tax Income |
(127)
N/A
|
(39)
+69%
|
114
N/A
|
81
-29%
|
172
+111%
|
80
-53%
|
78
-3%
|
(34)
N/A
|
(162)
-370%
|
(358)
-122%
|
(677)
-89%
|
(689)
-2%
|
(848)
-23%
|
(769)
+9%
|
(571)
+26%
|
(420)
+26%
|
(198)
+53%
|
(112)
+43%
|
(72)
+36%
|
(33)
+54%
|
(98)
-197%
|
(1 151)
-1 074%
|
(1 195)
-4%
|
|
Net Income | ||||||||||||||||||||||||
Tax Provision |
(78)
|
(85)
|
(28)
|
(36)
|
(28)
|
14
|
(10)
|
22
|
60
|
111
|
103
|
103
|
105
|
57
|
88
|
46
|
24
|
(23)
|
(6)
|
6
|
(16)
|
6
|
(36)
|
|
Income from Continuing Operations |
(205)
|
(125)
|
87
|
45
|
144
|
94
|
68
|
(13)
|
(102)
|
(247)
|
(574)
|
(586)
|
(743)
|
(712)
|
(483)
|
(374)
|
(174)
|
(135)
|
(78)
|
(27)
|
(114)
|
(1 145)
|
(1 231)
|
|
Net Income (Common) |
(172)
N/A
|
(91)
+47%
|
87
N/A
|
45
-48%
|
144
+218%
|
94
-35%
|
68
-28%
|
(13)
N/A
|
(102)
-702%
|
(247)
-142%
|
(574)
-133%
|
(586)
-2%
|
(743)
-27%
|
(712)
+4%
|
(483)
+32%
|
(374)
+23%
|
(174)
+53%
|
(135)
+22%
|
(78)
+42%
|
(27)
+65%
|
(114)
-322%
|
(1 145)
-904%
|
(1 231)
-8%
|
|
EPS (Diluted) |
-0.48
N/A
|
-0.24
+50%
|
0.24
N/A
|
0.11
-54%
|
0.39
+255%
|
0.26
-33%
|
0.18
-31%
|
-0.02
N/A
|
-0.25
-1 150%
|
-0.53
-112%
|
-1.3
-145%
|
-1.2
+8%
|
-1.54
-28%
|
-1.46
+5%
|
-0.99
+32%
|
-0.76
+23%
|
-0.35
+54%
|
-0.27
+23%
|
-0.16
+41%
|
-0.05
+69%
|
-0.23
-360%
|
-2.32
-909%
|
-2.5
-8%
|